BackSeelos Therapeutics Overview

Seelos Therapeutics Current Cash

Latest current cash for SEEL: $290K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$294000.00
94.97% YoYΔ $-5.55M vs prior year quarter

Peer average

Loading

Seelos Therapeutics Current Cash History

Loading

Seelos Therapeutics vs. peers: Current Cash Comparison

Loading

Seelos Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Seelos Therapeutics (SEEL) FAQ

Seelos Therapeutics (SEEL) currently reports a current cash of $290K as of June 2024. That compares with $5.8M in the prior-year period — down 95.0% year over year. Use the charts on this page to explore Seelos Therapeutics's current cash history and peer comparisons.

Seelos Therapeutics's current cash decreased from $5.8M to $290K — a 95.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seelos Therapeutics reported $290K in current cash as of June 2024. That compares with $5.8M in the prior-year period — down 95.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $290K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seelos Therapeutics, and consider following SEEL for alerts when major investors trade the stock.

Seelos Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $290K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SEEL with unrelated industries.